Τόμος 24 (2010) – Τεύχος 2 – Άρθρο 41 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 2 – Article 41 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Possible interactions with drugs of herbals used for weight loss enhancement
Authors Michael Chourdakis, Sofia Kellidou, Georgios Papazisis, Chrysanthi Sardeli, Anastasia Argyriou and Dimitrios Kouvelas

Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece

Citation Chourdakis, M., Kellidou, S., Papazisis, G., Sardeli, C. et al.: Possible interactions with drugs of herbals used for weight loss enhancement, Epitheorese Klin. Farmakol. Farmakokinet. 24(2): 128-129 (2010)
Publication Date 2010
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Herbals, weight loss, adverse effects, drug interactions.
Other Terms Review article
Summary The use of dietary supplements, including herbals, vitamins and minerals, is extensive. The majority of patients have little or no information about the possible risks and adverse effects from interactions with prescribed medicines. Concerns about herbal medications include their actual pharmacological properties. Among the more common herbs used for weight loss are Ephedra sinica (ephedra), Hoodia gordonii (hoodia), Citrus aurantium (bitter orange) and Larrea tridentate (chaparral), and are mostly used in an effort to enhance metabolism. Receiving ephedra with various medications may lead to interactions, (i.e. dysrythmias, hypertension, anxiety). Hoodia has been found to suppress appetite, however it has a potential hepatoxicity and therefore safety and efficacy have to be validated. Bitter orange acts similarly to ephedra and when received together with MAOIs can lead to tachycardia and hypertension. Chaparral acts similarly to caffeine and also has a mild diuretic effect. Its use may be complicated with renal, hepatic and neurological toxicity, and is also considered carcinogenic. Patients should be extremely cautious when receiving herbal medicines especially when are on any prescribed medication.
References 1. National Center for Complementary and Alternative Medicine: Ephedra. Herbs at a Glance 2006. http://nccam.nih.gov/health/ephedra/ataglance.htm

2. Kalix P.: The pharmacology of psychoactive alkaloids from ephedra and catha. J. Ethnopharmacol. 32: 201-208 (1991)

3. National Center for Complementary and Alternative Medicine: Ephedra. Consumer Advisory 2004 http://nccam.nih.gov/news/alerts/ephedra/consume-radvisory.htm

3. Tachjian A., Maria V., Jahangir A.: Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol. 55: 515-25.

5. van Heerden F.R., Marthinus Horak R., Maharaj V.J., Vleggaar R., Senabe J.V., Gunning P.J.: An appetite suppressant from Hoodia species. Phytochemistry 68: 2545-2553 (2007)

6. National Center for Complementary and Alternative Medicine: Herbs at a Glance. Hoodia. http://nccam.nih.gov/health/hoodia/

7. Bent S., Padula A., Neuhaus J.: Safety and efficacy of citrus aurantium for weight loss. Am. J. Cardiol. 94: 1359-1361 (2004)

8. Haaz S., Fontaine K.R., Cutter G., Limdi N., Perumean-Chaney S., Allison D.B.: Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes. Rev. 7: 79-88 (2006)

9. Kuhn M.A., Winston D.: Herbal Therapy and Supplements. Philadelphia, PA: Lippincott Williams & Wilkins, 2007

10. Rodriguez-Fragoso L., Reyes-Esparza J., Burchiel S.W., Herrera-Ruiz D., Torres E.: Risks and benefits of commonly used herbal medicines in Mexico. Toxicol. Appl. Pharmacol. 227: 125-135 (2008)

11. Holcomb S.S.: Common herb-drug interactions: what you should know. Nurse Pract. 34(5): 21-29 (2009)

12. Bishop F.L., Yardley L., Lewith G.T.: Treat or treatment: a qualitative study analyzing patients’ use of complementary and alternative medicine. Am. J. Public. Health 98: 1700-1705 (2008)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

Bookmark the permalink.

Comments are closed.